Home › Funds › Affinity Asset Advisors, LLC › SMMT

Affinity Asset Advisors, LLC position in SMMT

SUMMIT THERAPEUTICS INC · Health Care

Affinity Asset Advisors, LLC reported holding 1,700,000 shares of SMMT (SUMMIT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$28.7M, representing 1.34% of its reported portfolio and ranking #19 among its reported holdings. Affinity Asset Advisors, LLC has disclosed SMMT holdings in 5 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)1.70M sh
Reported value held$28.75M
Portfolio Weight1.34%
First reportedQ3 2024
Last changeAdd
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Affinity Asset Advisors, LLC's SMMT position evolved

Affinity Asset Advisors, LLC first disclosed a stake in SMMT in Q3 2024 at 140,000 shares (US$3.1M). The position peaked in Q3 2026 at 1,700,000 shares, worth US$28.7M. Across 5 filings, Affinity Asset Advisors, LLC increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 1,700,000 shares valued at US$28.7M — an increase of 1,600,000 shares quarter over quarter.. Notable position changes include a 1600% increase in Q3 2026 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 140.00K $3.07M New
Q3 2025 350.00K $7.23M New
Q4 2025 350.00K $6.12M Hold
Q2 2026 100.00K $1.46M New
Q3 2026 1.70M $28.75M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SMMT and 13F data

SMMT (SUMMIT THERAPEUTICS INC) is a Health Care company. 48 other funds we track also report a position in SMMT — the largest reported positions include BAKER BROS. ADVISORS LP (US$477.7M), Logos Global Management LP (US$19.7M), Octagon Capital Advisors LP (US$18.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SMMT

All SMMT fund holders →

FAQ

How long has Affinity Asset Advisors, LLC held SMMT?

Affinity Asset Advisors, LLC has disclosed SMMT holdings in 5 of the last 9 reported quarters, going back to Q3 2024.

What is Affinity Asset Advisors, LLC's current position in SMMT?

As of Q3 2026, Affinity Asset Advisors, LLC holds 1.70M shares of SMMT (SUMMIT THERAPEUTICS INC), valued at $28.75M, representing 1.34% of its reported portfolio and ranking #19.

Has Affinity Asset Advisors, LLC been buying or selling SMMT?

In the latest 13F filing (Q3 2026), Affinity Asset Advisors, LLC increased its position in SMMT. The position peaked in Q3 2026 at 1.70M shares.

Which other funds hold SMMT?

Other major institutional holders of SMMT include BAKER BROS. ADVISORS LP, Logos Global Management LP, Octagon Capital Advisors LP, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.